Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 10 of 10 for “"High throughput screening (Drug development)"”.
-
Developing tools to study CLIC5 biology in fibroblasts
… unknown but it has been implicated as one of the highly effector genes in GWAS studies of patients with osteoarthritis (OA) and has been involved in important biological processes such as cell migration, remodelling and inflammasome activation. <strong>Hypothesis.</strong> Because other CLIC …
-
Translational investigation of circadian rhythm modulating drugs on metabolic disorder
… and is recognised as a major risk factor for development of diabetes and cardiovascular diseases. Several key enzymes identified in this disorder are directly under circadian regulation and evidence from both pre-clinical research and epidemiological studies strongly implicate disturbed …
-
Development of high throughput screening systems for the efficient production of antibody fragments in Escherichia coli
… However, the production of antibody fragments in high yield for preclinical and clinical trials can be a serious bottleneck in drug discovery. This dissertation describes the development of novel screening systems for isolating antibody fragments and alternatively, E. coli genes, that facilitate …
-
Predicting the properties of ligands using molecular dynamics and machine learning
The discovery and design of new drugs requires extensive experimental assays that are usually very expensive and time-consuming. To cut down the cost and time of the drug development process and help design effective drugs more efficiently, various computational methods have been developed that are …
-
Inhibition of Ape1's DNA Repair Activity as a Target in Cancer: Identification of Novel Small Molecules that have Translational Potential for Molecularly Targeted Cancer Therapy
… function in cancer progression as wells as tumor drug response and will also give us a pharmacological tool to enhance cancer cells’ sensitivity to chemotherapy. In order to discover an inhibitor of Ape1’s DNA repair function, a fluorescence-based high-throughput screening (HTS) assay was used to …
-
PCAF, SIRT1 and the regulation of substrate acetylation
… assays. For this reason, a rapifleX MALDI-TOF MS high throughput screen (HTS) was developed to screen commercial libraries of histone peptides with combinatorial PTMs against PCAF and SIRT1 enzymes. This allows for mapping of PTM interactions with the enzymes, leading to changes in enzyme …
-
Development of 3D Porous Chitosan-Based Platform for In Vitro Culture
… 2D cell cultures in pharmaceutical companies for drug screening causes reproducibility issues in animal studies, which strongly influences the efficiency of drug development. The aim of my studies is to develop 3D cell culture models to better mimic the extracellular matrix (ECM) in tumor …
-
Discovery of novel regulators of aldehyde dehydrogenase isoenzymes
… associated with poor prognosis. Therefore, the development of inhibitors of the different ALDH enzymes is of interest as means to treat some of these disease states. Here I describe the results of assays designed to characterize the site of interaction and the mode of inhibition for the unique …
-
Automated High-throughput Analysis of Multi-class Multi-residue Pharmaceutical Drugs in Animal Tissue Using Solid Phase Microextraction
… diseases. Improper administration of these drugs may lead to excessive levels of drug residues in the edible tissues of treated animals, posing a potentially serious risk to human health. Accordingly, monitoring of veterinary drug residues is an integral component of food safety programs …
-
Identification, kinetic and structural characterization of small molecule inhibitors of aldehyde dehydrogenase 3a1 (Aldh3a1) as an adjuvant therapy for reversing cancer chemo-resistance
… based absorbance assay was optimized in a high throughput setting and 101, 000 compounds were screened and two new selective inhibitors for ALDH3A1, which have IC50 values of 0.2 µM (CB7) and 16 µM (CB29) were discovered. These two compounds compete for aldehyde binding, which was …